2nd June 2026
Ozempic and Muscle Loss: What GLP-1 Users Need to Know
Important Note
This article provides general fitness and health information about GLP-1 medications and exercise. It is not medical advice. If you are taking or considering GLP-1 medication, speak to your GP or prescribing clinician before making changes to your exercise or nutrition programme.
What Is This Guide?
This guide covers what GLP-1 medications (including Ozempic and Wegovy) are, how they cause muscle loss alongside fat loss, why that muscle loss matters, and what the evidence shows about using strength training to minimise it. It is aimed at people currently taking GLP-1 medication who also exercise, or who are considering both approaches together.
What Are GLP-1 Medications?
GLP-1 receptor agonists are a class of medications originally developed to treat type 2 diabetes that have become widely prescribed for weight loss. The most well-known include semaglutide (sold as Ozempic for diabetes and Wegovy for weight management) and tirzepatide (sold as Mounjaro and Zepbound).
They work by mimicking a naturally occurring gut hormone called glucagon-like peptide-1. This hormone slows gastric emptying, reduces appetite, and acts on brain receptors to increase feelings of fullness. The result is a significant reduction in calorie intake, which drives the weight loss GLP-1 drugs are known for.
Studies show adults taking GLP-1 medications typically lose between 5 and 15 percent of their starting body weight within a year.
The Muscle Loss Problem
The headline weight loss figures are impressive — but the number on the scale does not tell the full story. Research consistently shows that a substantial proportion of the weight lost on GLP-1 medications comes not from fat, but from lean mass — the term for muscle, bone and other non-fat tissue.
Estimates vary across studies, but research suggests that approximately 25 to 39 percent of total weight lost on GLP-1 medications may come from lean mass rather than fat. A 2026 analysis found that within a few years of starting treatment, people may experience a loss of muscle mass equivalent to around 20 years of normal age-related decline.
Why Does This Happen?
Two mechanisms drive muscle loss on GLP-1 medications:
- Appetite suppression reduces calorie and protein intake. Without adequate protein, the body has insufficient raw material to maintain muscle tissue. Without adequate total calories, it may break down muscle for fuel.
- GLP-1 suppresses glucagon — a hormone that plays a role in building and preserving muscle. Reduced glucagon activity can reduce the anabolic signal the body needs to maintain lean tissue.
Why Does Muscle Loss Matter?
Muscle loss is not simply an aesthetic concern. Its consequences extend across health, function and long-term weight management:
| Consequence of Muscle Loss | Why It Matters |
| Reduced resting metabolic rate | Less muscle means fewer calories burned at rest — making weight regain more likely if medication is stopped |
| Weakened strength and function | Loss of muscle affects everyday tasks, balance, posture and quality of life, particularly as we age |
| Increased fracture risk | Muscle loss is associated with reduced bone density. Emerging research links GLP-1 use with increased osteoporosis risk |
| Metabolic disadvantage | Loss of muscle impairs insulin sensitivity and glucose regulation — the very conditions GLP-1 drugs are often prescribed to manage |
| Sarcopenia acceleration | For older adults already experiencing age-related muscle loss, GLP-1-induced loss compounds the problem significantly |
What Does the Research Say About Strength Training and GLP-1s?
The evidence is consistent and clear: strength training is the most effective intervention for preserving lean muscle mass during GLP-1-induced weight loss. Medical professionals and obesity specialists now routinely advise that resistance training should be considered a companion to GLP-1 treatment, not an optional extra.
Dr. Amy Somerset, an obesity medicine specialist, states that people on GLP-1 medications can lose "anywhere from 10 to 40 percent of non-fat mass" and advises clients to increase both protein intake and strength training to preserve muscle. She notes that "losing muscle mass makes it very difficult to gain it back, especially after age 40."
Clinical trials are also exploring pharmacological approaches to the problem. An experimental muscle-preserving drug called bimagrumab has shown promise in helping people taking semaglutide retain muscle during weight loss — but strength training and adequate protein remain the most evidence-backed strategies available right now.
How to Minimise Muscle Loss on GLP-1 Medications
| Strategy | Guidance |
| Resistance training | Aim for 2 to 3 strength sessions per week targeting all major muscle groups. This sends the signal to the body that muscle is needed and should be retained. |
| Protein intake | Target 1.6 to 2.2g of protein per kilogram of bodyweight per day — the upper end of this range is advisable given appetite suppression makes total calorie intake lower. Prioritise protein at every meal. |
| Avoid extreme calorie restriction | GLP-1 medications already significantly reduce appetite. Avoid cutting calories further beyond the natural suppression — the body needs sufficient energy to preserve lean tissue. |
| Progressive overload | Gradually increase training weight or volume over time. The muscle-retention signal from training must be ongoing, not one-off. |
| Do not rely on cardio alone | Cardio burns calories but does not send the muscle-preservation signal that resistance training does. Cardio on its own during a GLP-1-induced deficit accelerates muscle loss. |
A Note on Stopping GLP-1 Medication
Most people who stop taking GLP-1 medications regain a significant proportion of lost weight. The risk of regain is substantially higher when the weight lost included a large proportion of muscle, because the reduction in resting metabolic rate makes energy balance harder to maintain. This is one of the strongest arguments for prioritising muscle preservation during treatment — not just for health during the medication period, but for long-term weight maintenance if and when the medication stops.
Key Takeaways
- GLP-1 medications like Ozempic produce significant weight loss, but an estimated 25 to 39 percent of that weight loss may come from lean muscle mass
- Muscle loss reduces resting metabolic rate, weakens functional strength, increases fracture risk and makes weight regain more likely after stopping medication
- Strength training 2 to 3 times per week is the most evidence-backed strategy for preserving muscle during GLP-1 treatment
- Protein intake of 1.6 to 2.2g per kilogram of bodyweight per day is essential — GLP-1-induced appetite suppression makes hitting this target more challenging
- Cardio alone does not protect muscle — resistance training is essential
